Some patients fear tirzepatide, sold by Eli Lilly under the brand names Zepbound and Mounjaro, will be hard to get and prohibitively expensive once compounding pharmacies are no longer producing it.

The diabetes and weight loss medications Ozempic and Wegovy are now considered to be available after more than two years ...

The Food and Drug Administration (FDA) recently removed Eli Lily's weight-loss drug from its shortage list, which some industry officials and medical experts argue will complicate access for some ...

Mounjaro, the brand name for tirzepatide could be available to nearly 250,000 people on the NHS. | Sandy Huffaker for The Washington Post via Getty Images Speaking about the plans, Dr Sam Roberts ...